MAPT and breast cancer: Although an increase in acetylated tubulin and a decrease in phosphorylated tau after Y-27632 treatment has been previously reported, we did not observe any significant change in acetylation of alpha-tubulin or tau phosphorylation upon ROCK inhibition in the breast cancer cells tested in adherent or suspended conditions (Figure 4A&B).